Erythromycin resistance and genetic elements carrying macrolide efflux genes in Streptococcus agalactiae

被引:44
作者
María-Marimón, J
Valiente, A
Ercibengoa, M
García-Arenzana, JM
Pérez-Trallero, E
机构
[1] Hosp Donostia, Microbiol Serv, San Sebastian 20014, Spain
[2] Univ Basque Country, Dept Med Prevent & Salud Publ, San Sebastian 20014, Spain
关键词
D O I
10.1128/AAC.49.12.5069-5074.2005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The macrolide resistance determinants and genetic elements carrying the mef(A) and mef(E) subclasses of the mef gene were studied with Streptococcus agalactiae isolated in 2003 and 2004 from 7,084 vaginorectal cultures performed to detect carrier pregnant women. The prevalence of carriage was 18% (1,276 isolates), and that of erythromycin resistance 11.0% (129 of the 1,171 isolates studied). erm(B), erm(A) subclass erm(TR), and the mef gene, either subclass mef(A) or mef(E), were found in 72 (55.8%), 41 (31.8%), and 12 (9.3%) erythromycin-resistant isolates, while 4 isolates had more than I erythromycin resistance gene. Of the 13 M-phenotype mef-containing erythromycin-resistant S. agalactiae isolates, It had the mef(E) subclass gene alone, one had both the mef(E) and the erm(TR) subclass genes, and one had the mef(A) subclass gene. mef(E) subclass genes were associated with the carrying element mega in 10 of the 12 mef(E)-containing strains, while the single mef(A) subclass gene found was associated with the genetic element Tn1207.3. The nonconjugative nature of the mega element and the clonal diversity of mef(E) -containing strains determined by pulsed-field gel electrophoresis suggest that transformation is the main mechanism through which this resistance gene is acquired.
引用
收藏
页码:5069 / 5074
页数:6
相关论文
共 33 条
  • [1] Molecular epidemiology of erythromycin resistance in Streptococcus pneumoniae isolates from blood and noninvasive sites
    Amezaga, MR
    Carter, PE
    Cash, P
    McKenzie, H
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (09) : 3313 - 3318
  • [2] Incidence of mefA and mefE genes in viridans group streptococci
    Arpin, C
    Canron, MH
    Maugein, J
    Quentin, C
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (09) : 2335 - 2336
  • [3] Presence of mefA and mefE genes in Streptococcus agalactiae
    Arpin, C
    Daube, H
    Tessier, F
    Quentin, C
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (04) : 944 - 946
  • [4] Structure and distribution of an unusual chimeric genetic element encoding macrolide resistance in phylogenetically diverse clones of group A Streptococcus
    Banks, DJ
    Porcella, SF
    Barbian, KD
    Martin, JM
    Musser, JM
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (12) : 1898 - 1908
  • [5] Rapid pulsed-field gel electrophoresis method for group B streptococcus isolates
    Benson, JA
    Ferrieri, P
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (08) : 3006 - 3008
  • [6] Erythromycin and clindamycin resistance and telithromycin susceptibility in Streptococcus agalactiae
    Betriu, C
    Culebras, E
    Gómez, M
    Rodríguez-Avial, I
    Sánchez, BA
    Agreda, MC
    Picazo, JJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (03) : 1112 - 1114
  • [7] Distribution and molecular analysis of mef(A)-containing elements in tetracycline-susceptible and -resistant Streptococcus pyogenes clinical isolates with efflux-mediated erythromycin resistance
    Brenciani, A
    Ojo, KK
    Monachetti, A
    Menzo, S
    Roberts, MC
    Varaldo, PE
    Giovanetti, E
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 54 (06) : 991 - 998
  • [8] Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1
  • [9] Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes
    Clancy, J
    Petitpas, J
    DibHajj, F
    Yuan, W
    Cronan, M
    Kamath, AV
    Bergeron, J
    Retsema, JA
    [J]. MOLECULAR MICROBIOLOGY, 1996, 22 (05) : 867 - 879
  • [10] Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada
    de Azavedo, JCS
    McGavin, M
    Duncan, C
    Low, DE
    McGeer, A
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (12) : 3504 - 3508